Related Experiment Videos
Prader-Willi syndrome
1Division of Human Genetics, University of Connecticut School of Medicine, Farmington.
Insights
Prader-Willi syndrome is diagnosed using clinical signs, though genetic testing is advancing. Research aims to identify specific genetic markers for a more consistent diagnosis of this complex genetic disorder.
Area of Science:
- Genetics
- Pediatrics
- Medical Diagnostics
Background:
- Prader-Willi syndrome (PWS) presents with hypotonia, failure to thrive, obesity, developmental delay, and characteristic physical features.
- Genetic abnormalities, particularly deletions on chromosome 15q11-q12, are found in over half of PWS cases.
- Current diagnosis relies heavily on clinical presentation due to limitations in genetic detection.
Purpose of the Study:
- To explore the genetic basis of Prader-Willi syndrome.
- To investigate potential etiologic heterogeneity within PWS.
- To identify reliable genetic markers for improved diagnostic accuracy.
Main Methods:
- Clinical assessment of patients with Prader-Willi syndrome.
- Prometaphase chromosome analysis to detect deletions in chromosome 15q11-q12.
- Application of molecular genetic technologies to the 15q region.
Main Results:
- A deletion of chromosome 15q11-q12 (del 15(q11-q12)) was identified in over 50% of individuals with PWS.
- A significant portion of patients presented with apparently normal chromosomes, suggesting other genetic factors may be involved.
- Molecular genetic studies are underway to further elucidate the genetic underpinnings.
Conclusions:
- Clinical criteria remain the primary method for diagnosing Prader-Willi syndrome.
- Molecular genetic analysis of chromosome 15 is crucial for identifying the genetic cause in a subset of patients.
- Further research is needed to identify consistent diagnostic markers and understand the full genetic spectrum of PWS.
Abstract:
People with Prader-Willi syndrome exhibit infantile hypotonia and failure to thrive, genital hypoplasia, childhood-onset obesity, mental deficiency and behavioral abnormalities, hypogonadism, short stature, and characteristic dysmorphology. In over half the affected individuals, prometaphase chromosome analysis reveals a small interstitial deletion of chromosome 15q, del 15(q11-q12); with most of the remaining patients showing apparently normal chromosomes. Molecular genetic technology is currently being applied to the relevant region of chromosome 15 to determine if there is etiologic heterogeneity and to seek a consistent diagnostic marker. Diagnosis at this time is primarily based upon clinical criteria.